IGC PHARMA, INC. Debt Instrument, Decrease, Forgiveness
IGC PHARMA, INC. (IGC) reported Debt Instrument, Decrease, Forgiveness of $430.00 thousand for the 9-month period ending 2021-12-31, per its 10-Q filed 2022-02-10.
Discontinued › Notes › Debt › Debt Instruments
us-gaap:DebtInstrumentDecreaseForgiveness · last filed 2022-02-10
- IGC PHARMA, INC. debt instrument, decrease, forgiveness for the quarter ending 2021-12-31 was $0.00.
- IGC PHARMA, INC. debt instrument, decrease, forgiveness for the quarter ending 2021-09-30 was $0.00.
- IGC PHARMA, INC. debt instrument, decrease, forgiveness for the quarter ending 2021-06-30 was $430.00K.
- IGC PHARMA, INC. debt instrument, decrease, forgiveness for the quarter ending 2020-12-31 was $0.00.
| Period end | Debt Instrument, Decrease, Forgiveness 3 month | Debt Instrument, Decrease, Forgiveness 6 month | Debt Instrument, Decrease, Forgiveness 9 month |
|---|---|---|---|
| 2021-12-31 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-02-10 | $0.00 derived: sum of 2 quarters · filed 2022-02-10 | $430.00K 10-Q · filed 2022-02-10 |
| 2021-09-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2021-10-29 | $430.00K 10-Q · filed 2021-10-29 | |
| 2021-06-30 | $430.00K 10-Q · filed 2021-08-11 | ||
| 2020-12-31 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-02-10 | $0.00 derived: sum of 2 quarters · filed 2022-02-10 | $0.00 10-Q · filed 2022-02-10 |
| 2020-09-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2021-10-29 | $0.00 10-Q · filed 2021-10-29 | |
| 2020-06-30 | $0.00 10-Q · filed 2021-08-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Hepion Pharmaceuticals, Inc. (HEPA) | United States | $0.029B | -0.62 |
| Transcode Therapeutics, Inc. (RNAZ) | United States | $0.029B | -0.12 |
| KYNTRA BIO, INC. (KYNB) | United States | $0.028B | 0.17 |
| BeyondSpring Inc. (BYSI) | United States | $0.031B | -10.95 |
| NANOVIRICIDES, INC. (NNVC) | United States | $0.031B | |
| CHINA PHARMA HOLDINGS, INC. (CPHI) | $0.032B | ||
| Propanc Biopharma, Inc. (PPCB) | $0.032B | -0.13 | |
| AYTU BIOPHARMA, INC (AYTU) | United States | $0.025B | -1.62 |
| Context Therapeutics Inc. (CNTX) | United States | $0.034B | -1.10 |
| NextCure, Inc. (NXTC) | United States | $0.024B | -0.15 |